|
Real-time Estimate
Cboe BZX
13:56:21 2026-10-01 EDT
|
5-day change | 1st Jan Change | ||
| 20.47 USD | -2.57% |
|
-8.33% | -33.76% |
| 08-14 | Oppenheimer Adjusts Pelthos Therapeutics PT to $64 From $66, Maintains Outperform Rating | MT |
| 08-13 | Pelthos Therapeutics Inc., Q2 2026 Earnings Call, Aug 13, 2026 |
Transcripts
Search
No results match your criteria
Select your edition
All financial news and data tailored to specific country editions
